Clinical Trial Update: Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) [Phase 4]

View source ↗

Summary

A Phase 4 trial (TANDEM) comparing Tarka (trandolapril/verapamil) with Lotrel (amlodipine/benazepril) in hypertensive, diabetic patients with renal disease has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus
• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• LOTREL (amlodipine besylate and benazepril hydrochloride)
• Tarka (trandolapril/verapamil)

Snippet

Sponsor: Abbott | Conditions: Hypertension, Diabetes | Phase 4 | Status: COMPLETED